COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
作者信息
Stringer Kathleen A, Puskarich Michael A, Kenes Michael T, Dickson Robert P
机构信息
Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan.
出版信息
Pharmacotherapy. 2020 May;40(5):382-386. doi: 10.1002/phar.2394. Epub 2020 May 4.
Abstract
摘要
相似文献
1
COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
Pharmacotherapy. 2020 May;40(5):382-386. doi: 10.1002/phar.2394. Epub 2020 May 4.
2
Curing COVID-19.
Lancet Infect Dis. 2020 Oct;20(10):1101. doi: 10.1016/S1473-3099(20)30706-4. Epub 2020 Sep 10.
3
Race to find COVID-19 treatments accelerates.
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
4
Puzzle of highly pathogenic human coronaviruses (2019-nCoV).
Protein Cell. 2020 Apr;11(4):235-238. doi: 10.1007/s13238-020-00693-y.
5
COVID-19: Stay Cool toward Corticosteroids.
Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.
6
Favipiravir, an antiviral for COVID-19?
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
7
World War against COVID-19: How strong is our armamentarium?
Med J Malaysia. 2020 May;75(3):314-315.
8
COVID-19 outbreak: the gold rush and the responsibilities of the scientific community.
Clin Microbiol Infect. 2020 Sep;26(9):1123-1124. doi: 10.1016/j.cmi.2020.05.002. Epub 2020 May 15.
9
COVID-19: Small-Molecule Clinical Trials Landscape.
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
10
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
引用本文的文献
1
Favipiravir Experience in COVID-19 Patients at a Tertiary Center Intensive Care Unit.
Sisli Etfal Hastan Tıp Bul. 2022 Jun 28;56(2):189-195. doi: 10.14744/SEMB.2021.35902. eCollection 2022.
2
Virology and Molecular Pathogenesis of Coronavirus Disease 2019: An Update.
Eurasian J Med. 2022 Oct;54(3):299-304. doi: 10.5152/eurasianjmed.2022.21133.
3
Perspectives from the frontline: A pharmacy department's response to the COVID-19 pandemic.
Am J Health Syst Pharm. 2020 Aug 20;77(17):1409-1416. doi: 10.1093/ajhp/zxaa176.
4
Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview.
Drugs Ther Perspect. 2020;36(10):455-462. doi: 10.1007/s40267-020-00761-7. Epub 2020 Jul 31.
本文引用的文献
1
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.
J Card Fail. 2020 May;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.
2
Management of Critically Ill Adults With COVID-19.
JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
4
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.
mBio. 2020 Mar 20;11(2):e00398-20. doi: 10.1128/mBio.00398-20.
5
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
6
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
9
COVID-19: a novel coronavirus and a novel challenge for critical care.
Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件